About Medivance
Medivance is a company based in Louisville (United States) founded in 1998 was acquired by CR Bard in October 2011. Medivance has raised $57.19 million across 5 funding rounds from investors including CR Bard, Camden Partners and Skyline Ventures. The company has 26 employees as of December 31, 2018. Medivance operates in a competitive market with competitors including ZOLL AEDs, Attune Medical, InnAccel, ART Medical and GlySure, among others.
- Headquarter Louisville, United States
- Employees 26 as on 31 Dec, 2018
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medivance Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Medivance
Medivance has successfully raised a total of $57.19M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $8.07 million completed in July 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Medivance
Medivance has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include CR Bard, Camden Partners and Skyline Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth equity investments are made in lower middle market companies.
|
Locked | Locked | Locked | |
|
US life sciences companies are invested in by Skyline Ventures.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Medivance
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medivance
Investment portfolio details for Medivance
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Medivance
Detailed financials for Medivance
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medivance Comparisons
Peer comparison for Medivance
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medivance
Medivance operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZOLL AEDs, Attune Medical, InnAccel, ART Medical and GlySure, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical devices and software for emergency care are developed.
|
|
| Locked | Locked | Locked |
Patient temperature is modulated via esophageal cooling devices.
|
|
| Locked | Locked | Locked |
Diversified medical devices are manufactured for critical and maternal care.
|
|
| Locked | Locked | Locked |
Safe enteral nourishment products for ICU patients are developed.
|
|
| Locked | Locked | Locked |
Continuous intravascular glucose monitoring is enabled by optical fluorescence sensors.
|
|
| Locked | Locked | Locked |
Continuous intravascular blood glucose monitoring devices are developed.
|
Detailed competitors of Medivance
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medivance
Complete news archive for Medivance
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medivance
Medivance was founded in 1998 and raised its 1st funding round 3 years after it was founded.
Medivance is headquartered in Louisville, United States. It is registered at Louisville, Kentucky, United States.
Medivance is a funded company, having raised a total of $57.19M across 5 funding rounds to date.
As of Dec 31, 2018, the latest employee count at Medivance is 26.
Medivance was founded in 1998 in Louisville, United States, and operates in the medical technology sector focused on therapeutic hypothermia. The Arctic Sun 5000 Temperature Management System is utilized to control patient temperatures between 32 and 38.5 degrees Celsius noninvasively. ArcticGel Pads are applied to the body, while temperature monitoring and adjustments are handled through a touchscreen interface that supports guided therapy protocols.
Medivance's top competitors include ZOLL AEDs, Inspiration Healthcare and InnAccel.
Medivance has 7 investors. Key investors include CR Bard, Camden Partners, Skyline Ventures, Partisan Management Group, and Cross Atlantic Partners.